Three new studies suggest that Ozempic and related diabetes and weight loss drugs may help protect the brain from strokes.

Q2 2025 Earnings Call Transcript August 4, 2025 Inspire Medical Systems, Inc. beats earnings expectations. Reported EPS is $0.45, expectations were $0.22. Operator: Good afternoon. My name is Dilem, ...

Inspire Medical Systems crashed Tuesday after the maker of implantable sleep apnea devices called out GLP-1 drugs for ...

Inspire Medical stock falls as Q2 earnings beat is overshadowed by guidance cut and slower U.S. rollout of its newly approved ...

Shares of medical technology company Inspire Medical Systems (NYSE:INSP) fell 41.3% in the afternoon session after the ...

Inspire Medical Systems (INSP) stock drops despite strong Q2 2025 results as it cuts 2025 forecasts amid headwinds to Inspire ...

Investing.com -- Inspire Medical Systems (NYSE: INSP) stock plunged 27% after the company’s disappointing quarterly results and guidance prompted four Wall Street firms to downgrade the shares.

Baron Funds, an investment management company, released its “Baron Discovery Fund” second-quarter 2025 investor letter. A copy of the letter can be downloaded here.

My doctor shamed me when I asked about weight loss drugs. But they've helped me lose 80 pounds and stop binge eating. "Yay science." ...

Sharon Osbourne lost weight with the help of Ozempic after calling herself a 'food addict' and ultimately warning against the use of weight loss medication. Here's everything Sharon Osbourne has ...

New research reveals why standard weight loss advice may not work for everyone. Discover how doctors are rethinking health and what really matters for you.

Weight loss drugs linked to disordered eating in boys and men Weight loss drugs pose a danger to boys and men. A study of the drugs Ozempic and Wegovy found that males who used them experienced ...